By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: Hai Ling Appointed to Manulife’s Board of Directors
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > News > Hai Ling Appointed to Manulife’s Board of Directors
Hai Ling Appointed to Manulife’s Board of Directors
News

Hai Ling Appointed to Manulife’s Board of Directors

Last updated: 13/11/2025 1:36 PM
Published: 13/11/2025
Share
SHARE

C$ unless otherwise stated                                        TSX/NYSE/PSE: MFC     SEHK: 945

- Advertisement -

TORONTO, Nov. 12, 2025 /PRNewswire/ — Manulife Financial Corporation (“Manulife”) announced today that Hai Ling has been appointed to its Board of Directors, effective January 1, 2026.

- Advertisement -

Mr. Ling is the President for Asia Pacific, Europe, the Middle East and Africa at Mastercard Inc., where he serves on both its Executive Leadership Team and global Management Committee. He has also held executive roles at Bank of America and HSBC. Mr. Ling holds a Doctor of Humane Letters and a Bachelor of Science in Business Administration from the College of Saint Rose, and an MBA from the University of Chicago Booth School of Business.

- Advertisement -

“Hai brings significant financial services experience that will be valuable in supporting the effective oversight of Manulife’s strategy and operations,” said Don Lindsay, Chair of the Board, Manulife. “He is an accomplished executive with significant global and Asia market knowledge, and we are excited for him to join Manulife and our Board.”

- Advertisement -

Mr. Ling will serve on the Audit Committee and Corporate Governance and Nominating Committee.

- Advertisement -

About Manulife

- Advertisement -

Manulife Financial Corporation is a leading international financial services provider, helping our customers make their decisions easier and lives better. With our global headquarters in Toronto, Canada, we operate as Manulife across Canada, Asia, and Europe, and primarily as John Hancock in the United States, providing financial advice and insurance for individuals, groups and businesses. Through Manulife Wealth & Asset Management, we offer global investment, financial advice, and retirement plan services to individuals, institutions, and retirement plan members worldwide. At the end of 2024, we had more than 37,000 employees, over 109,000 agents, and thousands of distribution partners, serving over 36 million customers. We trade as ‘MFC’ on the Toronto, New York, and the Philippine stock exchanges, and under ‘945’ in Hong Kong.

- Advertisement -

Not all offerings are available in all jurisdictions. For additional information, please visit manulife.com. 

- Advertisement -

Media Contact
Fiona McLean
Manulife
(437) 441-7491
fiona_mclean@manulife.com

- Advertisement -

Investor Relations
Derek Theobalds
Manulife
(416) 254-1774
derek_theobalds@manulife.com 

- Advertisement -
Criminal IP to Showcase ASM and CTI Innovations at GovWare 2025 in Singapore
Cureus Updates Terms & Conditions to Prohibit AI Use
Peer-Reviewed Study in Nature Scientific Reports Demonstrates Non-Invasive Fat Reduction Using Alma’s Energy-Based Technology
Vaxxas Secures TGA Licence to Manufacture Therapeutic Goods
3D Concrete Printed Resort Delivers Measurable Gains One Year Into Operations
TAGGED:appointedboarddirectorshailingmanulife’snews
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis
Health

New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis

GlobeNews Wire
GlobeNews Wire
30/03/2026
Cactus Communications and NIT Calicut Partner to Bring AI Research Tools to Academics
GPS Renewables raises 635 crore in Series C Funding
Jasper Therapeutics Reports Positive Data from 180mg Cohort in SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria
PT Infomedia Nusantara Receives Frost & Sullivan’s 2025 Indonesian Customer Experience Management Services Company of the Year Recognition for Excellence in Digital Transformation and AI-Driven Customer Engagement
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?